INSECTICIDES (INDIA) LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 579 INR | -0.28% |
|
+0.31% | -14.46% |
| Mar. 26 | Insecticides Limited Announces Reconstitution of Committees | CI |
| Feb. 06 | Transcript : Insecticides Limited, Q3 2024 Earnings Call, Feb 06, 2024 |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -14.46% | 205M | - | ||
| +2.08% | 3.62B | C- | ||
| -17.29% | 2.23B | C+ | ||
| -9.08% | 1.94B | B- | ||
| +2.07% | 1.85B | - | ||
| -1.75% | 1.67B | - | ||
| -1.72% | 1.3B | B | ||
| +7.87% | 1.23B | - | ||
| -20.13% | 1.06B | - | ||
| -3.74% | 997M | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
- Stock Market
- Equities
- INSECTICID Stock
- Ratings Insecticides (India) Limited
